Gilead Sciences Inc. (NASDAQ:GILD)
Market Cap: $143.15 billion, EPS: $9.48, Dividend Yield: 1.73%, P/E:10.29
Gilead Sciences Inc. (NASDAQ:GILD) is a biotech company busy finding and developing treatments for diseases with unmet medical needs and holds therapeutics for HIV/AIDS, Hepatitis B & C, cancer, heart diseases, and respiratory diseases which it sells in the Americas and worldwide. The company has witnessed increasing revenues and earnings, with significant growth in the last two years.
Gilead has the lowest P/E ratio amongst the five stocks I’ve picked, indicating its cheap valuation. The company has strong fundamentals with an attractive debt-to-equity ratio under one, more than twice the current assets than current liabilities, and returns of 1.73% in dividend yield.